CLINICAL TRIALS
It can normally take 10 to 15 years to develop a vaccine against a given infectious disease. After decades of research, there is still no vaccine against HIV. The Ebola vaccine Merck developed in four years is one of the fastest on record. However, HIV, Ebola, and other diseases don’t have the same everyday impact on huge swaths of people in developed nations the way COVID-19 does, and they don’t disrupt the world economy to anywhere near the same extent. So the imperative for a COVID-19 vaccine is much higher. Governments are eager to invest in one because solving this problem solves a lot of other problems.
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Travel Well in 2025
The best places to see & best things to do in the new year
Getting Back to giving
How to revive charitable donations, with Charitybuzz CEO Ben Erwin
Breathtaking BUILDINGS
THE WORLD'S MOST AWE-INSPIRING EDIFICES
ALong for the Ride
Clean energy projects go up in areas once dominated by fossil fuels
HEALTHCARE ANALYTICS: FIGHTING THE GOOD FIGHT
Advanced analytics are transforming healthcare operations and patient care. Nevada's Renown Health is leading the way, creating a roadmap for swift and effective change.
THE RIGHT ACCELERANT
THE POSSIBILITIES - AND LIMITATIONS OF AI IN SCIENTIFIC RESEARCH
IN GLOBAL LOGISTICS
How thinking global and acting local is enlarging the global footprint of the Staci Group
THE RIGHT STUFF
Why veterans thrive in logistics
LIVING MACHINES
BIOHYBRIDS BRING THE POWER OF NATURE TO ROBOTICS
MANUFACTURING'S NEW LOOK
The industry’s reputation doesn’t match reality, but the future is bright